Allogeneic Hematopoietic Cell Transplantation clinical trials

Explore recruiting allogeneic hematopoietic cell transplantation clinical trials.

Recruiting allogeneic hematopoietic cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allogeneic Hematopoietic Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications

Germany, France, Belgium, Spain, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Assessment of Tolerance and Effectiveness of Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Allogeneic hematopoietic cell transplantation from HLA-matched donor after Flu-Mel-PTCy versus Flu-Mel-ATG reduced-intensity conditioning: a phase II randomized study from the Belgian Hematology Society (BHS)

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (allo HCT)

Germany, Italy, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Preemptive treatment with venetoclax plus azacitidine in patients diagnosed with acute myeloid leukemia (AML) with persistence or reappearance of measurable residual disease (MRD) after frontline chemotherapy and high-level MRD prior to allogeneic hematopoietic cell transplantation (alloHCT)

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Allogeneic Hematopoietic Cell Transplantation trials by city

Allogeneic Hematopoietic Cell Transplantation in Toronto Allogeneic Hematopoietic Cell Transplantation in Vancouver Allogeneic Hematopoietic Cell Transplantation in Montreal Allogeneic Hematopoietic Cell Transplantation in Calgary Allogeneic Hematopoietic Cell Transplantation in Edmonton Allogeneic Hematopoietic Cell Transplantation in Ottawa Allogeneic Hematopoietic Cell Transplantation in Winnipeg Allogeneic Hematopoietic Cell Transplantation in Quebec City Allogeneic Hematopoietic Cell Transplantation in Hamilton Allogeneic Hematopoietic Cell Transplantation in Kitchener Allogeneic Hematopoietic Cell Transplantation in London Allogeneic Hematopoietic Cell Transplantation in Halifax Allogeneic Hematopoietic Cell Transplantation in New York Allogeneic Hematopoietic Cell Transplantation in Los Angeles Allogeneic Hematopoietic Cell Transplantation in Chicago Allogeneic Hematopoietic Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease